The regulatory environment for animal health is in flux. More products were approved in 2025 than in any year since 2021, expedited pathways are being used more creatively, and the growing wave of biologics submissions is testing frameworks that were built for small molecules. We'll explore how the landscape is shifting and what that means for companies with assets in development.
Speaker(s):
Time:
10:00am-10:30am
Agenda Track No.:
Track 8
Session Type:
General Session (Presentation)
Force Inline Description:
0